Skip to main content

Table 7 Spearman’s correlation coefficient between the cellular factors with the HPV and EBV genes

From: Possible role of HPV/EBV coinfection in anoikis resistance and development in prostate cancer

  LMP-1 LMP-2 EBER 1 EBER 2 E2 E6 E7
NF-κB 0.6**** 0.43*** 0.33** 0.31** 0.37** 0.64**** 0.64****
TNF-α 0.49** 0.18 ns 0.19 ns 0.28* 0.271** 0.50*** 0.504***
IL-1 0.501** 0.42** 0.34** 0.22* 0.40*** 0.533*** 0.529***
IL-6 0.66*** 0.41** 0.11 ns 0.28* 0.309** 0.444*** 0.435***
IL-8 0.54*** 0.11 ns 0.07ns 0.08 ns 0.393** 0.603*** 0.596***
IL-11 0.55*** 0.3* 0.34* 0.136 ns 0.341*** 0.504*** 0.509***
IL-17 0.56*** 0.41** 0.104 ns 0.09 ns 0.420*** 0.726*** 0.724***
VEGF 0.57**** 0.39* 0.302* 0.07 ns 0.323** 0.595*** 0.604***
TGF-β 0.51*** 0.25* 0.103 ns −0.08 ns 0.31** 0.55*** 0.59****
Rb −0.47*** 0.39** 0.28** 0.22* −0.553*** −0.751*** −0.751***
P53 −0.51*** −0.401* −0.201* −0.05 ns −0.456*** −0.712*** −0.715***
Survivin 0.76**** 0.39** 0.308** 0.17 ns 0.528*** 0.757*** 0.761***
Bcl-2 0.49*** 0.39** 0.102 ns −0.03 ns 0.556*** 0.743*** 0.743***
ROS 0.46** 0.29* 0.09 ns 0.105 ns 0.525*** 0.763*** 0.763***
RNS 0.301* 0.08 ns 0.02 ns 0.106 ns 0.460*** 0.654*** 0.652***
CD44 0.8**** 0.68**** 0.48*** 0.58**** 0.21* 0.34** 0.29**
TWIST 0.53**** 0.44*** 0.44*** 0.045 ns 0/53** 0/83**** 0/86****
E-cad −0.5*** −0.2* − 0.11* − 0.096 ns − 0/47** − 0/71*** −0/71***
N-cad 0.51**** 0.41** 0.42** 0.206 * 0/51** 0/85**** 0/87****
PTPN13 −0.409*** − 0.15 ns −0.15 ns − 0.01 ns − 0/48** −0/41* − 0/38*
SLUG 0.35* 0.05 ns 0.05 ns 0.10 ns 0/35* 0/46** 0/46**
  1. ns: not significant, * p < 0.05; ** p < 0.01; *** p < 0.001, **** < 0.0001